Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · IEX Real-Time Price · USD

1.100

0.00 (0.00%)

At close: May 3, 2024, 4:00 PM

1.120

+0.020 (1.82%)

After-hours: May 3, 2024, 4:42 PM EDT

Bolt Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-69.2	-88.1	-98.59	-60.73	-30.49	-11.59
Depreciation & Amortization	4.81	4.89	3.67	2.5	1.33	0.3
Share-Based Compensation	9.22	9.58	8.5	1.42	0.51	0.12
Other Operating Activities	-14.36	-2.87	29.35	9.5	2.31	1.29
Operating Cash Flow	-69.53	-76.5	-57.07	-47.31	-26.34	-9.87
Capital Expenditures	-0.21	-1.95	-2.34	-3.26	-0.51	-0.29
Change in Investments	71.24	59.82	-229.86	-17.33	0	0
Investing Cash Flow	71.04	57.86	-232.2	-20.59	-0.51	-0.29
Share Issuance / Repurchase	0.25	0.5	259.21	0.29	0.07	0.02
Debt Issued / Paid	0	0	0	0	-0.04	-0.04
Other Financing Activities	-	-	51.9	39.3	48.6	19.11
Financing Cash Flow	0.25	0.5	311.11	39.6	48.63	19.09
Net Cash Flow	1.77	-18.14	21.84	-28.3	21.78	8.93
Free Cash Flow	-69.73	-78.46	-59.4	-50.57	-26.85	-10.16
Free Cash Flow Margin	-885.36%	-1369.47%	-4714.60%	-21891.77%	-12488.84%	-
Free Cash Flow Per Share	-1.84	-2.10	-1.79	-24.05	-13.47	-6.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).